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Abstract 
This study aimed to describe blood pressure (BP) and hypertension (HT) in samples of high altitude 
populations of Nepal and to explore associations of systolic and diastolic BP with altitude. This was a 
cross-sectional survey of cardiovascular disease and associated risk factors among 521 people living 
at four different altitude levels, all above 2800 m, in the Mustang and Humla districts of Nepal. Data 
on BP was available for all 521 participants. Systolic and diastolic BP levels were highest at the 
altitude of 3620 m (the highest area surveyed) but did not consistently increase with altitude. Using 
the cut-point of ≥140/90 mmHg (systolic/diastolic), the prevalence of HT (or on anti-hypertensive 
medication) was 46.1%, 40.9%, and 54.5% respectively at 2800 m, 3270 m and 3620 m of Mustang 
district, and 29.1% at 2890 m of Humla district. In a multivariate model adjusting for potential 
confounders there was strong evidence of a relationship between systolic BP and altitude; mean 
systolic BP increased by 15.6 mmHg (95% CI 4.0 to 27.2), P=0.009 for every 1000 m elevation. 
Although diastolic BP and the probability for HT or on anti-hypertensive medication also tended to 
increase with increasing altitude levels, there was no evidence of a relationship. In the present study 
three out of four communities living at higher altitude levels showed a greater prevalence of HT 
among those aged 30 years or older compared with the overall national data. These findings indicate a 
probable high risk of raised BP in high altitude populations in Nepal.  
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Introduction 
The effect of chronic hypoxic hypobaric conditions, induced by living at high altitude (HA), on blood 
pressure (BP) is uncertain and may vary in different populations. Research on this relationship and 
other cardiopulmonary changes at HA has been ongoing for more than 50 years
1
, however, it is still 
uncertain whether the relationship between BP and hypertension (HT) and HA is causal, or a result of 
coincident lifestyle factors. An inverse association between altitude and systemic BP may be due to, 
separately or in combination with, structural changes in vasculature; and a number of socio-cultural, 
biological, chemical and physical factors.
2, 3
 However, the possible benefit from altitude related 
hypoxia on systemic BP may diminish when genetic and lifestyle related risk factors become 
dominant, as seen in Tibetan origin populations.
4, 5
  
An altitude of 2500 metre (m) or above is the conventional demarcation for HA,
6
 however it is not 
uniformly defined in the scientific literature. Using this definition, more than 140 million people in 
the world permanently live at HA, comprising 2% of the global population.
7
 Established human 
populations living in the Ethiopian summits of Africa, the Himalayan mountains of Asia, and the 
Andean mountains of South America have a long history of HA residency: 70,000 years, 25,000 
years, and 11,000 years respectively.
8
 The largest populations at HA are 80 million in the Himalayan 
mountains of Asia and 35 million in the Andean mountains of South America.
7
 
In Nepal, almost 2 million people live permanently in mountainous areas, representing 7% of the 
national population.
9
 A large proportion of the population of the hilly districts are also resident at 
altitudes greater than 2500 m. According to earlier estimates, around 35% of the total Nepalese 
population permanently live at higher than 2500 m of elevation.
7
 Populations with Tibetan ancestry 
are the dominant HA population in Nepal.  
There are few studies on HA living populations in Nepal. But none of them had information collected 
at different altitude levels above 2500 m and from ethnically diverse samples. This study aims to 
report the relationship between BP and altitude at four different altitude levels and tests the hypothesis 
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that despite known hypoxia-induced favourable physiological responses on BP, HA residents in Nepal 
might have an increased risk of raised BP associated with lifestyle factors.  
Methods 
Study setting and sample 
Two mountainous districts, Mustang and Humla, were selected for sampling based on past 
documentation of geography, altitude, population and ethnicity and the feasibility for conducting the 
study. There are 16 districts classified as mountain ecological regions in Nepal. The selected study 
areas were, in Mustang district, urban settings of Jomsom (2800 m) and Muktinath (3620 m), and a 
rural setting of Jharkot (3270 m); and in Humla district, a  rural setting of Simikot (2890 m). The 
population with Tibetan ancestry is predominant in Mustang district, whereas Khas-Aryan population 
has a majority in Humla. Mustang people are relatively wealthy and the dominant Thakali ethnic 
group has the highest human development index (HDI) score in Nepal
10
 which is largely due to 
tourism and natural resources. In contrast, the Humla district has the lowest HDI score
10
. Tibetan 
culture is influential in both these districts because both are bordered with Tibetan sides of China. Life 
expectancy at birth is 64.1 years in Mustang and 65.0 years in Humla, both lower than the national 
figure of 68.8 years
10
. 
Tibetans migrated to high mountains of Nepal about 500 years ago. Tibeto-Burman is their native 
language and they practice Buddhism
11
. Thakali, Tibetan Gurung, and Lama of the study's population 
belong to this category. Khas-Aryans migrated to Nepal about 2000 years ago, speak the Nepalese 
language, and the majority of them are Hindu
12
. Brahmins, Chettris, and Dalits are mainly categorized 
as Khas-Arya
13
. Tibetans and Khas-Aryans have distinctive physical appearances, languages, and 
names. 
The inclusion criteria for study participants were age 30 years and above and the ability to speak and 
understand the Nepalese language. Exclusion criteria were the inability or unwillingness to provide 
written or verbal consent, inability to speak or hear properly, and pregnancy. 
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Sampling process 
Sampling was carried out in two stages. In the first stage, three study areas of Mustang and one study 
area of Humla were selected on the basis of altitude levels, population density and logistical support 
to undertake the study. In the second stage, a list of households was developed, and a unique number 
was assigned to each of them. Household numbers were randomly selected with the help of a 
computer based randomization technique. All eligible family members of the randomly selected 
households were considered. If none of the household members were eligible or agreed to take part in 
the study, a household in the close proximity was selected. 
The desired sample size within each district was calculated to be around 250 individuals. This sample 
size gave a margin of error of plus or minus 5% for a proportion based on anticipated prevalence of 
HT of around 25% after adjusting for the design effect and an expected non-response rate of 10%.  
Data collection procedures 
The World Health Organization's STEPS questionnaire version 2.2 for non-communicable disease 
risk factors was administered to consenting participants. This questionnaire has three sections. The 
first section has questions on socio-demographic and lifestyle factors, a second section consists of BP 
and anthropometric (height, weight, waist, hip) measurements, and the third section contains 
measurements of blood glucose and lipids. The Nepal Health Research Council (NHRC) had already 
translated this into the Nepalese language and it has been validated through a pilot study in a 
community and approved by expert meetings
14
.  
Administration of the questionnaire and BP measurements were carried out at the house of the 
selected participants. Practically it was not feasible to undertake blood sample testing for lipid 
components and glycated hemoglobin (HbA1c), and bio-physical measurements in individual houses 
so a local community hall was used as the measurement facility.  
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Data was collected between June and August (summer) 2014 in Mustang district and between March 
and May (spring) 2015 in Humla district. The ambient temperature was between 25
°
C and 31°C in 
Mustang and around 15°C in Humla on most of study days. 
BP was measured by oscillometric method using an automatic blood pressure measuring device 
(Omron HEM-7221).  The recommended operating ambient pressure conditions of this machine are 
from 700 to 1060 hectopascals. This is the atmospheric pressure at around 3000 m. Moreover, Omron 
BP monitoring machines have also passed the validation criteria at 3650 m as proposed by the 
European Society of Hypertension International Protocol Revision 2010 (ESH-IP2) 
15
. Three readings 
were recorded from left arm of each participant in sitting position with at least 10 minutes elapsing in 
between. The first measurement was taken a minimum of 10 minutes after the questionnaire was 
administered. If the readings differed by more than 10 units, a fourth measurement was taken and the 
lowest three were considered for an average calculation. HbA1c and lipid profiles were measured 
using a Cobas b 101 device (Roche Diagnostics). A small amount of capillary whole blood was taken 
by single finger-prick and processed by the device. 
Definitions 
Blood pressure (systolic/diastolic) was classified as normal (<120/80 mmHg), pre-HT (120–39/80–89 
mmHg), HT (≥140/90 mmHg), Stage I HT (140–159/90–99 mmHg), and Stage II HT (≥160/100 
mmHg) according to the seventh report of the Joint National Committee on prevention, detection, 
evaluation, and treatment of high blood pressure
16
. Alcohol consumption-related questions were about 
current, past and ‘ever drinking’ status, frequency of drinking, and the number of standard drink units 
(SDUs) consumed in the past 30 days. Current drinkers were defined as those drinking alcohol in the 
past 30 days. SDU of alcohol was calculated by the formula: 
Amount of drink (Litre)(l) x percent of volume of alcohol (%) x density of ethanol at room temperature 
(0.789)
17
. 
A glass with 90 millilitre (mL) volume was a popular size in the study areas. The few participants 
who consumed alcohol in different-sized glasses were asked to estimate the volume with reference to 
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a 90 mL glass. Traditionally home-made and locally brewed alcoholic beverages were popular in the 
study areas, mainly jaad (made of rice), chang (also made of rice but using a different method), and 
raksi (made of rice, millet or barley). The percentage of volume of alcohol was determined as 12% for 
jaad and chang, 25% for raksi
18
, and 5.5% for beer and 40% for vodka as labelled. 
The amount of salt consumption was determined by asking how much participants estimated their 
household consumed in a month, and this amount was divided by the number of family members 
currently sharing the kitchen for the main meal. Salt was usually available in one kilogram (kg) 
packets.  
Statistical methods 
Simple data description is by mean, standard deviation (SD), frequency counts, and proportions 
expressed as percentages. The Clopper-Pearson method was used to estimate an exact confidence 
interval for a single proportion. All results are presented for each level of altitude. Analysis of 
variance (ANOVA) and analysis of covariance (ANCOVA) models for the relationship between 
systolic blood pressure (SBP), diastolic blood pressure (DBP) and altitude are shown. Logistic 
regression was used to estimate the association between HT or on antihypertensive medication and 
altitude. Altitude was treated as a continuous variable in the multivariate models. Other included 
variables in multivariate models were age, sex, weight, salt intake, alcohol consumption (SDUs) in the 
past 30 days, urban or rural residential setting, and current smoking status. Stata version 12 was used 
for data analysis.  
This study was approved by the ethical review board of NHRC and the University of Otago, Human 
Ethics Committee.  
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Results 
A total of 521 HA residents at four different altitude levels participated in this study; 2800 m 
(N=165), 3270 m (N=61) and 3620 m (N=44) of the Mustang district and 2890 m (N=251) of the 
Humla district. More than 70% of participants in Mustang had Tibetan ancestry and  >70% in Humla 
were Khas-Aryans. Particular ethnic groups amongst Tibetan related participants were: Thakali, 
Tibetan Gurung and Lama; and for Khas-Aryans: Brahmin, Chhetri, and Dalit. Participants are 
described in Table 1. 
Figure 1 shows boxplots of  SBP and DBP by the levels of altitude. The mean SBP and DBP were 
highest at the highest altitude of 3620 m but did not consistently increase with increasing altitude. 
There was strong evidence that SBP and DBP were different across the altitude levels. The F-statistics 
from the analysis of variance (ANOVA) with SBP as the response variable and altitude as a 
categorical predictor variable was 12.6 (3 DF, 517), P <0.01; and for DBP, 3.64 (3 DF, 517), P=0.01.  
Summaries of HT-related characteristics at different altitude levels are shown in Table 2. Residents at 
3620 m had higher proportions of participants with HT and related characteristics than those at lower 
altitude. Participants who were men, in older age groups, with formal school education, higher self-
reported annual household income and currently married were more likely to have HT (or be on anti-
hypertensive medication). Men had higher levels of SBP and DBP at each altitude level compared 
with women, however, this differences were statistically significant at 2890 m only, for both SBP and 
DBP. Overall, men had almost two-fold higher odds than women for being hypertensive or on anti-
hypertensive medication: age adjusted odds ratio (95% CI) of 1.96 (1.34 to 2.86), P <0.01.  
By self-report about half of the participants at all altitude stated they were current consumers of 
alcohol. A higher proportion of men were current drinkers compared to women at every altitude level. 
At least a quarter of the current drinkers or current smokers were hypertensive or on anti-hypertensive 
medication at all altitude levels. There were no significant differences between currently smoking 
status, current consumers of alcohol and having hypertension (or on anti-hypertensive medication) at 
any altitude level. Hypertensive residents at all altitude levels usually reported that on average they 
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consumed less fruit and vegetables and more salt per day compared to non-hypertensives, however, 
the difference was statistically significant only at 2800 m for average fruit and vegetables 
consumption only. Although differences were statistically non-significant, those with HT (or on anti-
hypertensive medication) were generally physically less active and sedentary at all altitude levels 
compared to non-hypertensives. 
Participants with Tibetan ethnicity had a higher proportion of HT (or being on anti-hypertensive 
medication) compared to Khas-Aryans; however, when adjusted for age and sex the odds ratio (95% 
CI) for HT (or being on anti-hypertensive medication) among participants with Tibetan compared to 
Khas-Aryan was 0.86 (0.58 to 1.29), P=0.49.  
In a multivariate model adjusting for potential confounders there was strong evidence of a relationship 
between SBP and altitude (Table 3). Mean SBP (95% CI) increased by 15.6 mmHg (4.0 to 27.2), 
P=0.009 for every 1000 m elevation. Older age, self-reported SDUs of alcohol in the past 30 days, and 
being urban residents were associated with higher mean SBP.   
Table 4 shows the estimates of the associations between DBP and altitude and other covariates. In the 
multivariate model adjusting for the potential confounders, the relationship between DBP and altitude 
was positive, albeit with wide confidence interval. Mean (95% CI) DBP increased by 7.2 mmHg (-0.2 
to 14.6), P=0.05 per 1000 m higher altitude. Among the covariates, higher weight and a greater 
number of SDUs of alcohol in the past 30 days was associated with higher DBP. Unexpectedly, there 
was a negative relationship of self-reported salt intake with both mean SBP and DBP, however these 
did not reach the level of statistical significance.  
While adjusting for the same confounding variables as for mean SBP and DBP, the odds ratio (95% 
CI) for being hypertensive or on anti-hypertensive medication was 2.21 (0.55 to 8.96), P=0.26 per 
1000 m higher altitude. Among the covariates, only older age was significantly associated with the 
probability for having hypertension or on anti-hypertensive medication. 
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Discussion 
The present study found a strong association between SBP and altitude. Although point estimates for 
the associations between DBP and HT (or on anti-hypertensive medication) and increasing altitude 
levels were consistent with a positive association, confidence intervals for the estimates of 
associations were wide. This study did not identify any association between HT (or use of anti-
hypertensive medication) and ethnicity (categorized as Tibetan related or Khas-Aryan). Men were 
more likely to have higher SBP and DBP than women at every altitude level. 
A recent systematic review reported a weak positive association between SBP, DBP and altitude in 
populations of Tibetan origin but in non-Tibetan populations both SBP and DBP tended to decrease 
with residence at higher altitude, although there were wide confidence intervals
19
. Another systematic 
review including studies conducted in Tibet reported a 2% increment in the prevalence of HT for 
every 100 m increment in altitude
5
. These findings are consistent with findings in the present study 
where, although participants were from both Tibetan and Khas-Aryan ethnicities, the geographical 
location of the study districts border on the Tibetan side of China and Khas-Aryans have consequently 
acquired Tibetan lifestyle practices, mainly drinking tea made with salty butter and high amounts of 
alcohol.  In the present study, approximately half of the participants at all altitude levels self-reported 
being current drinkers, which is greater than the national prevalence of 21.5% for the Nepalese 
population aged older than 30 years
14
. This may well contribute to the association between SBP and 
altitude regardless of ethnicity. Nonetheless, the association between altitude and SBP was found even 
after controlling for alcohol and salt intake, which may indicate that the HA environment itself is an 
additional independent factor in determining the high prevalence of HT although there may also be an 
underlying genetic risk 
4, 20
. 
The lack of significant association of DBP with altitude – although this association was positive – 
may be partly due to the significant number of participants aged 60 years or above (around one-fifth) 
and it is well established that DBP falls with ageing while SBP continues to rise
21
. Although the 
present study's finding of multivariate adjusted associations between BP and age, alcohol intake, and 
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urban lifestyle is consistent with past research the inverse relationship between self-reported daily salt 
consumption and BP is not 
22, 23
. High consumption of salt as a traditional dietary habit has been 
identified as one of the key factors for high BP in HA Tibetan populations 
24, 25
. The method used in 
the present study of self-report to calculate salt consumption could have systematically led to 
underestimation of salt intake in those with the highest salt intake. 
The prevalence of HT (or those on anti-hypertensive medication) in participants in the present study is 
higher than in other studies carried out in HA populations in Nepal using a similar definition 
26-28
. 
Two possible explanations for this difference are the different ages of the study samples and a cohort 
effect. The minimum age to participate in the present study was 30 years, whereas other studies 
usually included participants from the age of 18 years or over. HT may be increasing in prevalence 
with the passage of time for reasons other than lifestyle, ethnicity or altitude. However, in the present 
study, the prevalence of HT (or those on anti-hypertensive medication) in the Mustang district 
(Tibetan related participants), is close to that reported in HA studies carried out on Tibetans living in 
Tibet or in India 
29-31
. The prevalence of HT (or being on anti-hypertensive medication) in Mustang 
was higher than the national prevalence of Nepal for the population aged 30 years or over (36.8%)
14
, 
but was lower in the Humla district with its dominant Khas-Aryan population. In the present study the 
prevalence of raised BP was high, but actual diagnosis and treatment of HT was very poor. Nearly 
one-quarter of the study participants and two-thirds of hypertensives were diagnosed with HT for the 
first time during the study. 
The main strength of the present study for the relationship between BP and HA is that presumably this 
is the first study to collect information at four different altitude levels above or equal to 2500 m and 
from ethnically diverse samples. The present study has several limitations. Multiple potential 
confounding and effect modification factors could explain an apparent relationship between SBP and 
altitude; mainly genetic risk, cultural-related lifestyle practices, socio-economic status, and residential 
settings (rural versus urban). These differences are accounted for where relevant data were available 
but these inter-relationships are complex. Other limitations are: selection of the study sites on the 
basis of logistic convenience for the study conduct, low population density and consequently a low 
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sample size at 3270 m and 3620 m of Mustang district, reliance on self-report in an area of poor 
health literacy and the cross-sectional design. There is also the risk of 'healthy individual effect' 
because, in the absence of quality health care, people with HT might have moved to low altitude areas 
for treatment or died, so reported prevalence might not reflect true incidence. On the other hand, it is 
also likely that healthy young populations of study areas may have internally migrated to city areas or 
emigrated to other countries for job, education or for other reasons. Thus, this 'migration effect' could 
have missed eligible young and healthy individuals in the survey. Finally, there was a notable 
difference in the ambient temperature of two study districts at the time of data collection. Temperature 
of Humla was lower by between 10 °C to 16 °C than that of Mustang. As there is some evidence that 
lower ambient temperature increases BP in adults 
32
, difference of temperature in study districts might 
have modified the effect of altitude on BP. 
In conclusion, there was a strong evidence of a relationship between SBP and altitude, and no 
evidence of a relationship between DBP, HT and altitude, after adjustment for potential confounding 
variables. The prevalence of HT was higher in three out of four altitude levels compared to the 
national prevalence of Nepal for populations aged 30 years or older. These findings indicate a 
probable high risk of raised BP in HA populations in Nepal and clinicians should be aware about it. 
Furthermore, the present study also observed that the non-Tibetan HA population of Nepal has 
acquired Tibetan lifestyle habits, which may increase the risk of HT in the future. Public health 
awareness on healthier lifestyle as well as clinical intervention campaign for diagnosis, treatment, and 
control of HT are recommended in these HA populations. There is very limited research about BP 
among the non-Tibetan HA populations in Nepal. More data and analysis of these populations will 
help to better understand the HA and BP relationship. Although high intake of salt and heavy alcohol 
drinking are mainly attributed for raised BP in HA populations of Nepal, information on uptake levels 
by objective measures is limited. Comparisons of HA populations with homogeneous counterparts 
who later migrated to low altitude may also provide important insights into this relationship.  
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Figure 1: Box plot of systolic and diastolic blood pressure values by altitude level 
 
 
 
